NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

抗菌藥市場 - 預測,主要企業分析,COVID-19復甦方案:2020年∼2030年

Antibacterial Drugs Market Report 2020-2030: Forecasts by Type, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Others, by Distribution Channel, by Region, Analysis of Leading Drug Discovery Outsourcing Companies, COVID-19 Recovery Scenarios

出版商 Visiongain Ltd 商品編碼 963245
出版日期 內容資訊 英文 391 Pages
商品交期: 最快1-2個工作天內
價格
抗菌藥市場 - 預測,主要企業分析,COVID-19復甦方案:2020年∼2030年 Antibacterial Drugs Market Report 2020-2030: Forecasts by Type, Penicillins, Fluoroquinolones, Macrolides, Carbapenems, Others, by Distribution Channel, by Region, Analysis of Leading Drug Discovery Outsourcing Companies, COVID-19 Recovery Scenarios
出版日期: 2020年08月20日內容資訊: 英文 391 Pages
簡介

本報告提供全球抗菌藥市場相關調查分析,主要趨勢,R&D的進展,收益預測,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 摘要整理

第3章 全球抗菌藥市場概要

  • 市場趨勢分析
    • 促進因素
    • 阻礙因素
    • 機會
  • SWOT分析
  • 波特的五力分析
  • 產業分析:PEST分析
  • 價值鏈分析

第4章 全球抗菌藥市場規模預測:各類型

  • 頭孢菌素
  • 青霉素
  • Fluoroquinolones
  • 大環內酯類
  • 碳青霉烯類
  • 其他

第5章 全球抗菌藥市場規模預測:各頭孢菌素

  • Rocephin
  • Sulperazon
  • Ceftin/Zinnat
  • Meiact
  • Flomox
  • Teflaro
  • Zeftera
  • Ceftolozane-tazobactam
  • Zavicefta (CAZ-AVI) (Ceftazidime-Avibactam)
  • 其他

第6章 全球抗菌藥市場規模預測:各青霉素

  • Generic Amoxicillin
  • Augmentin
  • Zosyn/Tazocin
  • Unasyn
  • Generic amoxicllin-clavulanic acid
  • Amoxil
  • 其他

第7章 全球抗菌藥市場規模預測:各Fluoroquinolones

  • Avelox
  • Cravit/Levaquin (levofloxacin)
  • Vigamox
  • Ciprodex
  • Cipro/Cirpobay
  • Geninax
  • Baxdela
  • 其他

第8章 全球抗菌藥市場規模預測:各大環內酯類

  • Biaxin/Clarith
  • Zithromax
  • Dalacin
  • Dificid
  • Solithromycin
  • 其他

第9章 全球抗菌藥市場規模預測:各碳青霉烯類

  • Invanz
  • Merrem/Meropen
  • Primaxin
  • Doribax
  • 其他

第10章 全球抗菌藥市場規模預測:各其他部門

  • Zyvox
  • Cubicin
  • Tygacil
  • TOBI/TIP
  • Solodyn
  • Vibativ
  • Sirturo
  • Tedizolid
  • Oritavancin
  • Dalbavancin
  • Nemonoxacin
  • Surotomycin
  • 其他

第11章 全球抗菌藥市場規模預測:各流通管道

  • 醫院藥局
  • 藥妝店、零售藥局
  • 電子商務

第12章 各地區、主要國家的抗菌藥市場預測

  • 各國市場預測

第13章 北美

第14章 歐洲

第15章 亞太地區

第16章 南美

第17章 中東、非洲

第18章 抗菌藥市場主要企業

  • Pfizer Inc.
  • Novartis AG
  • Merck KGaA
  • GlaxoSmithKline PLC
  • BioVersys AG
  • Allecra Therapeutics GmbH
  • Adenium Biotech ApS
  • Bayer AG
  • Eli Lilly and Company
  • AstraZeneca PLC
  • AbbVie Inc.
  • Melinta Therapeutics
  • SHIONOGI Co., Ltd.
  • DAIICHI SANKYO COMPANY, LIMITED.
  • Johnson & Johnson Services, Inc.

第19章 結論與建議

目錄
Product Code: PHA0401

Title:
Antibacterial Drugs Market Report 2020-2030
Forecasts by Type (Cephalosporins (Rocephin, Sulperazon, Ceftin/Zinnat, Meiact, Flomox, Teflaro, Zeftera, Ceftolozane-tazobactam, Ceftazidime-Avibactam, Others), Penicillins (Generic amoxicillin, Augmentin, Zosyn/Tazocin, Unasyn, Generic Amoxicllin-clavulanic Acid, Amoxil, Others), Fluoroquinolones (Avelox, Cravit, Vigamox, Ciprodex, Cipro/Cirpobay, Geninax, Baxdela, Others), Macrolides (Biaxin/Clarith, Zithromax, Dalacin, Dificid, Solithromycin, Others), by Carbapenems (Invanz, Merrem/Meropen, Primaxin, Doribax, Others), Others (Zyvox, Cubicin, Tygacil, TOBI/TIP, Solodyn, Vibativ, Sirturo, Tedizolid, Oritavancin, Dalbavancin, Nemonoxacin, Surotomycin)), by Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, E-Commerce), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) and Analysis of Leading Drug Discovery Outsourcing Companies. PLUS, COVID-19 Recovery Scenarios.

Antibacterial Drugs - our new study reveals trends, R&D progress, and predicted revenues

Where is the Antibacterial Drugs market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 391 page report provides 231 Tables and 285 Figures. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Antibacterial Drugs Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market drivers, restraints/challenges, opportunities, PEST, SWOT, and Porter's Fiver Forces Analysis), company profiles (financials 2015 to 2020, products, recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Discover sales predictions for the world market and submarkets

Global Antibacterial Drugs Market Segmentation

By Type

  • Cephalosporins
  • Penicillins
  • Fluoroquinolones
  • Macrolides
  • Carbapenems
  • Others

By Cephalosporins

  • Rocephin
  • Sulperazon
  • Ceftin/Zinnat
  • Meiact
  • Flomox
  • Teflaro
  • Zeftera
  • Ceftolozane-tazobactam
  • Ceftazidime-Avibactam

By Penicillins

  • Generic Amoxicillin
  • Augmentin
  • Zosyn/Tazocin
  • Unasyn
  • Generic amoxicllin-clavulanic acid
  • Amoxil
  • Others

By Fluoroquinolones

  • Avelox
  • Cravit
  • Vigamox
  • Ciprodex
  • Cipro/Cirpobay
  • Geninax
  • Baxdela
  • Others

By Macrolides

  • Biaxin/Clarith
  • Zithromax
  • Dalacin
  • Dificid
  • Solithromycin
  • Others

By Carbapenems

  • Invanz
  • Merrem/Meropen
  • Primaxin
  • Doribax
  • Others

By Other Sectors

  • Zyvox
  • Cubicin
  • Tygacil
  • TOBI/TIP
  • Solodyn
  • Vibativ
  • Sirturo
  • Tedizolid
  • Oritavancin
  • Dalbavancin
  • Nemonoxacin
  • Surotomycin
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of MEA
Pic.

The report also includes profiles and for some of the leading 15 companies in the Antibacterial Drugs Market, with a focus on this segment of these companies' operations.

Leading 15 companies and the potential for market growth

Overall world revenue for Antibacterial Drugs Market will surpass US$xx million in 2020, our work calculates. We predict a growth rate of over xx% from 2020 to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Antibacterial Drugs Market report helps you

In summary, our 391 pages report provides you with the following knowledge:

  • Revenue forecasts to 2030 for Antibacterial Drugs Market, with forecasts for Intranasal Antihistamines, Intranasal Corticosteroids, Oral Antihistamines, Immunotherapy and Vaccines, Others, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2030 for 5 regional and 18 key national markets - See forecasts for the Antibacterial Drugs market in North America, Europe, Asia-Pacific, Latin America and MEA. Also, the report provides forecasts for all the major economies such as U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, GCC, and South Africa
  • Prospects for established firms and those seeking to enter the market- including company profiles for Pfizer Inc., Novartis AG, Merck & Co. Inc., GlaxoSmithKline PLC, BioVersys AG, Allecra Therapeutics GmbH, Adenium Biotech ApS, Bayer AG, Eli Lilly and Company, Johnson & Johnson Services, Inc., AstraZeneca PLC, Allergan, Melinta Therapeutics, SHIONOGI Co., Ltd., and DAIICHI SANKYO COMPANY, LIMITED involved in the Antibacterial Drugs Market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Antibacterial Drugs Market and leading companies. You will find data, trends and predictions.

Buy our Global Antibacterial Drugs Market Analysis. today and Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1 Report Overview

  • 1.1 Introduction to Antibacterial Drugs Market
  • 1.2 Global Antibacterial Drugs Market Segmentation
  • 1.3 Why You Should Read This Report
  • 1.4 What This Report Delivers
  • 1.5 Key Questions Answered By This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1. COVID-19 Impact: Recovery Scenarios
    • 1.7.2. Market Evaluation & Forecasting Methodology
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Global Antibacterial Drugs Market Overview

  • 3.1 Market Trend Analysis
    • 3.1.1. Drivers
      • 3.1.1.1. Rise in Bacterial Infections
      • 3.1.1.2. Growth Strategies Adopted by Market Players
    • 3.1.2. Restraints
      • 3.1.2.1. Economic Barriers of Antibiotic R&D
      • 3.1.2.2. Misuse of Antibiotics and Resistance Crisis
      • 3.1.2.3. Generic Erosion and Prescription Control Will Limit Market Growth
      • 3.1.2.4. Other Factor Challenging Market Growth
      • 3.1.2.5. Resistance to Commonly Prescribed Antibacterial
    • 3.1.3. Opportunities
      • 3.1.3.1. Growing Demand From Emerging Economies
      • 3.1.3.2. Introduction of new approaches for managing bacterial infections
  • 3.2 SWOT Analysis
    • 3.2.1. Strengths
    • 3.2.2. Weaknesses
    • 3.2.3. Opportunities
    • 3.2.4. Threats
  • 3.3 Porter's Five Forces
    • 3.3.1. Low Buyer Power
    • 3.3.2. Low Supplier Power
    • 3.3.3. Highly Competitive Rivalry
    • 3.3.4. Low Threat of Substitute
    • 3.3.5. Moderate Threat of New Entrants
  • 3.4 Industry analysis - PEST Analysis
    • 3.4.1. Political
      • 3.4.1.1. Regulatory requirements must be simplified and harmonized globally
      • 3.4.1.2. Government bodies are investing heavily in antibiotic development
      • 3.4.1.3. Governments and regulatory agencies are incentivizing antibiotic development
    • 3.4.2. Economical
      • 3.4.2.1. Big pharma companies have decreased investment in this sector, but there are many small biotech with innovative products
      • 3.4.2.2. Generic use is widespread in the antibacterial drugs industry
      • 3.4.2.3. Potential returns on investment need to increase
    • 3.4.3. Social
      • 3.4.3.1. Bacterial infections represent a major disease burden
      • 3.4.3.2. Increasing incidence of serious diseases
      • 3.4.3.3. Frequent multinational travel is helping to spread drug-resistant strains rapidly
    • 3.4.4. Technological
      • 3.4.4.1. Improved diagnostics will allow for better selection of the appropriate therapy
      • 3.4.4.2. Novel biologics such as bacteriophages are in early stages of development
      • 3.4.4.3. New technologies will improve HAI prevention
  • 3.5 Value Chain Analysis

4 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Type

  • 4.1 Cephalosporins: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.1.1. "V" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.1.2. "U" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.1.3. "W" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.1.4. "L" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 4.2 Penicillins Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.2.1. "V" Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.2.2. "U" Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.2.3. "W" Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.2.4. "L" Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 4.3 Fluoroquinolones Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.3.1. "V" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.3.2. "U" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.3.3. "W" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.3.4. "L" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 4.4 Macrolides Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.4.1. "V" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.4.2. "U" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.4.3. "W" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.4.4. "L" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 4.5 Carbapenems Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.5.1. "V" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.5.2. "U" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.5.3. "W" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.5.4. "L" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 4.6 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.6.1. "V" Shaped Recovery: Global Antibacterial Drugs Market for Others Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.6.2. "U" Shaped Recovery: Global Antibacterial Drugs Market for Others Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.6.3. "W" Shaped Recovery: Global Antibacterial Drugs Market for Others Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 4.6.4. "L" Shaped Recovery: Global Antibacterial Drugs Market for Others Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)

5 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Cephalosporins

  • 5.1 Rocephin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 5.2 Sulperazon Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 5.3 Ceftin/Zinnat Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 5.4 Meiact Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 5.5 Flomox Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 5.6 Teflaro Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 5.7 Zeftera Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 5.8 Ceftolozane-tazobactam Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 5.9 Zavicefta (CAZ-AVI) (Ceftazidime-Avibactam) Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 5.10 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)

6 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Penicillins

  • 6.1 Generic Amoxicillin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 6.2 Augmentin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 6.3 Zosyn/Tazocin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 6.4 Unasyn Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 6.5 Generic amoxicllin-clavulanic acid Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 6.6 Amoxil Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 6.7 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)

7 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Fluoroquinolones

  • 7.1 Avelox Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 7.2 Cravit/Levaquin (levofloxacin) Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 7.3 Vigamox Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 7.4 Ciprodex Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 7.5 Cipro/Cirpobay Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 7.6 Geninax Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 7.7 Baxdela Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 7.8 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)

8 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Macrolides

  • 8.1 Biaxin/Clarith Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 8.2 Zithromax Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 8.3 Dalacin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 8.4 Dificid Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 8.5 Solithromycin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 8.6 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)

9 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Carbapenems

  • 9.1 Invanz Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 9.2 Merrem/Meropen Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 9.3 Primaxin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 9.4 Doribax Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 9.5 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)

10 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Other Sectors

  • 10.1 Zyvox Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.2 Cubicin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.3 Tygacil Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.4 TOBI/TIP Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.5 Solodyn Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.6 Vibativ Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.7 Sirturo Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.8 Tedizolid Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.9 Oritavancin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.10 Dalbavancin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.11 Nemonoxacin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.12 Surotomycin Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 10.13 Others Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)

11 Global Antibacterial Drugs Market Size Forecast 2020-2030 by Distribution Channel

  • 11.1 Global Antibacterial Drugs Market for Hospital Pharmacies Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.1.1. "V" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.1.2. "U" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.1.3. "W" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.1.4. "L" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 11.2 Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.2.1. "V" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.2.2. "U" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.2.3. "W" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.2.4. "L" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • 11.3 Global Antibacterial Drugs Market for E-Commerce Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.3.1. "V" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.3.2. "U" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.3.3. "W" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 11.3.4. "L" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)

12 Regional and Leading National Antibacterial Drugs Market Forecasts 2020-2030

  • 12.1 Global Antibacterial Drugs Market by National Market Forecast 2020-2030
    • 12.1.1. "V" Shaped Recovery: Global Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 12.1.2. "U" Shaped Recovery: Global Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 12.1.3. "W" Shaped Recovery: Global Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
    • 12.1.4. "L" Shaped Recovery: Global Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)

13 North America

  • 13.1 North America Antibacterial Drugs Market by Country Forecast 2020-2030
  • 13.2 North America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
  • 13.3 North America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
  • 13.4 U.S. Antibacterial Drugs Market Forecast 2020-2030
    • 13.4.1. "V" Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast 2020-2030
    • 13.4.2. "U" Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast 2020-2030
    • 13.4.3. "W" Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast 2020-2030
    • 13.4.4. "L" Shaped Recovery Scenario: U.S .Antibacterial Drugs Market Forecast 2020-2030
  • 13.5 Canada Antibacterial Drugs Market Forecast 2020-2030
    • 13.5.1. "V" Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast 2020-2030
    • 13.5.2. "U" Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast 2020-2030
    • 13.5.3. "W" Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast 2020-2030
    • 13.5.4. "L" Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast 2020-2030

14 Europe

  • 14.1 Europe Antibacterial Drugs Market by Country Forecast 2020-2030
  • 14.2 Europe Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
  • 14.3 Europe Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
  • 14.4 Germany Antibacterial Drugs Market Forecast 2020-2030
    • 14.4.1. "V" Shaped Recovery Scenario: Germany Antibacterial Drugs Market Forecast 2020-2030
    • 14.4.2. "U" Shaped Recovery Scenario: Germany Antibacterial Drugs Market Forecast 2020-2030
    • 14.4.3. "W" Shaped Recovery Scenario: Germany Antibacterial Drugs Market Forecast 2020-2030
    • 14.4.4. "L" Shaped Recovery Scenario: Germany Antibacterial Drugs Market Forecast 2020-2030
  • 14.5 France Antibacterial Drugs Market Forecast 2020-2030
    • 14.5.1. "V" Shaped Recovery Scenario: France Antibacterial Drugs Market Forecast 2020-2030
    • 14.5.2. "U" Shaped Recovery Scenario: France Antibacterial Drugs Market Forecast 2020-2030
    • 14.5.3. "W" Shaped Recovery Scenario: France Antibacterial Drugs Market Forecast 2020-2030
    • 14.5.4. "L" Shaped Recovery Scenario: France Antibacterial Drugs Market Forecast 2020-2030
  • 14.6 UK Antibacterial Drugs Market Forecast 2020-2030
    • 14.6.1. "V" Shaped Recovery Scenario: UK Antibacterial Drugs Market Forecast 2020-2030
    • 14.6.2. "U" Shaped Recovery Scenario: UK Antibacterial Drugs Market Forecast 2020-2030
    • 14.6.3. "W" Shaped Recovery Scenario: UK Antibacterial Drugs Market Forecast 2020-2030
    • 14.6.4. "L" Shaped Recovery Scenario: UK Antibacterial Drugs Market Forecast 2020-2030
  • 14.7 Italy Antibacterial Drugs Market Forecast 2020-2030
    • 14.7.1. "V" Shaped Recovery Scenario: Italy Antibacterial Drugs Market Forecast 2020-2030
    • 14.7.2. "U" Shaped Recovery Scenario: Italy Antibacterial Drugs Market Forecast 2020-2030
    • 14.7.3. "W" Shaped Recovery Scenario: Italy Antibacterial Drugs Market Forecast 2020-2030
    • 14.7.4. "L" Shaped Recovery Scenario: Italy Antibacterial Drugs Market Forecast 2020-2030
  • 14.8 Spain Antibacterial Drugs Market Forecast 2020-2030
    • 14.8.1. "V" Shaped Recovery Scenario: Spain Antibacterial Drugs Market Forecast 2020-2030
    • 14.8.2. "U" Shaped Recovery Scenario: Spain Antibacterial Drugs Market Forecast 2020-2030
    • 14.8.3. "W" Shaped Recovery Scenario: Spain Antibacterial Drugs Market Forecast 2020-2030
    • 14.8.4. "L" Shaped Recovery Scenario: Spain Antibacterial Drugs Market Forecast 2020-2030
  • 14.9 Russia Antibacterial Drugs Market Forecast 2020-2030
    • 14.9.1. "V" Shaped Recovery Scenario: Russia Antibacterial Drugs Market Forecast 2020-2030
    • 14.9.2. "U" Shaped Recovery Scenario: Russia Antibacterial Drugs Market Forecast 2020-2030
    • 14.9.3. "W" Shaped Recovery Scenario: Russia Antibacterial Drugs Market Forecast 2020-2030
    • 14.9.4. "L" Shaped Recovery Scenario: Russia Antibacterial Drugs Market Forecast 2020-2030
  • 14.10 Rest of Europe Antibacterial Drugs Market Forecast 2020-2030
    • 14.10.1. "V" Shaped Recovery Scenario: Rest of Europe Antibacterial Drugs Market Forecast 2020-2030
    • 14.10.2. "U" Shaped Recovery Scenario: Rest of Europe Antibacterial Drugs Market Forecast 2020-2030
    • 14.10.3. "W" Shaped Recovery Scenario: Rest of Europe Antibacterial Drugs Market Forecast 2020-2030
    • 14.10.4. "L" Shaped Recovery Scenario: Rest of Europe Antibacterial Drugs Market Forecast 2020-2030

15 Asia Pacific

  • 15.1 Asia Pacific Antibacterial Drugs Market by Country Forecast 2020-2030
  • 15.2 Asia Pacific Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
  • 15.3 Asia Pacific Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
  • 15.4 Japan Antibacterial Drugs Market Forecast 2020-2030
    • 15.4.1. "V" Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast 2020-2030
    • 15.4.2. "U" Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast 2020-2030
    • 15.4.3. "W" Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast 2020-2030
    • 15.4.4. "L" Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast 2020-2030
  • 15.5 China Antibacterial Drugs Market Forecast 2020-2030
    • 15.5.1. "V" Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast 2020-2030
    • 15.5.2. "U" Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast 2020-2030
    • 15.5.3. "W" Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast 2020-2030
    • 15.5.4. "L" Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast 2020-2030
  • 15.6 India Antibacterial Drugs Market Forecast 2020-2030
    • 15.6.1. "V" Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast 2020-2030
    • 15.6.2. "U" Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast 2020-2030
    • 15.6.3. "W" Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast 2020-2030
    • 15.6.4. "L" Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast 2020-2030
  • 15.7 Australia Antibacterial Drugs Market Forecast 2020-2030
    • 15.7.1. "V" Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast 2020-2030
    • 15.7.2. "U" Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast 2020-2030
    • 15.7.3. "W" Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast 2020-2030
    • 15.7.4. "L" Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast 2020-2030
  • 15.8 15.8 South Korea Antibacterial Drugs Market Forecast 2020-2030
    • 15.8.1. "V" Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast 2020-2030
    • 15.8.2. "U" Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast 2020-2030
    • 15.8.3. "W" Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast 2020-2030
    • 15.8.4. "L" Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast 2020-2030
  • 15.9 Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030
    • 15.9.1. "V" Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030
    • 15.9.2. "U" Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030
    • 15.9.3. "W" Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030
    • 15.9.4. "L" Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030

16 Latin America

  • 16.1 Latin America Antibacterial Drugs Market by Country Forecast 2020-2030
  • 16.2 Latin America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
  • 16.3 Latin America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
  • 16.4 Brazil Antibacterial Drugs Market Forecast 2020-2030
    • 16.4.1. "V" Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
    • 16.4.2. "U" Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
    • 16.4.3. "W" Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
    • 16.4.4. "L" Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
  • 16.5 Mexico Antibacterial Drugs Market Forecast 2020-2030
    • 16.5.1. "V" Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
    • 16.5.2. "U" Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
    • 16.5.3. "W" Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
    • 16.5.4. "L" Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
  • 16.6 Argentina Antibacterial Drugs Market Forecast 2020-2030
    • 16.6.1. "V" Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
    • 16.6.2. "U" Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
    • 16.6.3. "W" Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
    • 16.6.4. "L" Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
  • 16.7 16.7 Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
    • 16.7.1. "V" Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
    • 16.7.2. "U" Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
    • 16.7.3. "W" Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
    • 16.7.4. "L" Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030

17 Middle East and Africa

  • 17.1 Middle East and Africa Antibacterial Drugs Market by Country Forecast 2020-2030
  • 17.2 Middle East and Africa Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
  • 17.3 Middle East and Africa Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
  • 17.4 GCC Antibacterial Drugs Market Forecast 2020-2030
    • 17.4.1. "V" Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
    • 17.4.2. "U" Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
    • 17.4.3. "W" Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
    • 17.4.4. "L" Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
  • 17.5 South Africa Antibacterial Drugs Market Forecast 2020-2030
    • 17.5.1. "V" Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
    • 17.5.2. "U" Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
    • 17.5.3. "W" Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
    • 17.5.4. "L" Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
  • 17.6 Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
    • 17.6.1. "V" Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
    • 17.6.2. "U" Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
    • 17.6.3. "W" Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
    • 17.6.4. "L" Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030

18 Major Companies in the Antibacterial Drugs Market

  • 18.1 Pfizer Inc.
    • 18.1.1. Pfizer Inc.: Company Snapshot
    • 18.1.2. Pfizer Inc.: Company Overview
    • 18.1.3. Pfizer Inc.: Financials
    • 18.1.4. Pfizer Inc.: Recent Developments
  • 18.2 Novartis AG
    • 18.2.1. Novartis AG: Company Snapshot
    • 18.2.2. Novartis AG: Company Overview
    • 18.2.3. Novartis AG: Financials
    • 18.2.4. Novartis AG: Recent Developments
  • 18.3 Merck KGaA
    • 18.3.1. Merck KGaA: Company Snapshot
    • 18.3.2. Merck KGaA: Company Overview
    • 18.3.3. Merck KGaA: Financials
    • 18.3.4. Merck KGaA: Recent Developments
  • 18.4 GlaxoSmithKline PLC
    • 18.4.1. GlaxoSmithKline PLC: Company Snapshot
    • 18.4.2. GlaxoSmithKline PLC: Company Overview
    • 18.4.3. GlaxoSmithKline PLC: Financials
    • 18.4.4. GlaxoSmithKline PLC: Recent Developments
  • 18.5 BioVersys AG
    • 18.5.1. BioVersys AG: Company Snapshot
    • 18.5.2. BioVersys AG: Company Overview
    • 18.5.3. BioVersys AG: Financials
    • 18.5.4. BioVersys AG: Recent Developments
  • 18.6 Allecra Therapeutics GmbH
    • 18.6.1. Allecra Therapeutics GmbH: Company Snapshot
    • 18.6.2. Allecra Therapeutics GmbH: Company Overview
    • 18.6.3. Allecra Therapeutics GmbH: Financials
    • 18.6.4. Allecra Therapeutics GmbH: Recent Developments
  • 18.7 Adenium Biotech ApS
    • 18.7.1. Adenium Biotech ApS: Company Snapshot
    • 18.7.2. Adenium Biotech ApS: Company Overview
    • 18.7.3. Adenium Biotech ApS: Financials
    • 18.7.4. Adenium Biotech ApS: Recent Developments
  • 18.8 Bayer AG
    • 18.8.1. Bayer AG: Company Snapshot
    • 18.8.2. Bayer AG: Company Overview
    • 18.8.3. Bayer AG: Financials
    • 18.8.4. Bayer AG: Recent Developments
  • 18.9 Eli Lilly and Company
    • 18.9.1. Eli Lilly and Company: Company Snapshot
    • 18.9.2. Eli Lilly and Company: Company Overview
    • 18.9.3. Eli Lilly and Company: Financials
    • 18.9.4. Eli Lilly and Company: Recent Developments
  • 18.10 AstraZeneca PLC
    • 18.10.1. AstraZeneca PLC: Company Snapshot
    • 18.10.2. AstraZeneca PLC: Company Overview
    • 18.10.3. AstraZeneca PLC: Financials
    • 18.10.4. AstraZeneca PLC: Recent Developments
  • 18.11 AbbVie Inc.
    • 18.11.1. AbbVie Inc.: Company Snapshot
    • 18.11.2. AbbVie Inc.: Company Overview
    • 18.11.3. AbbVie Inc.: Financials
    • 18.11.4. AbbVie Inc.: Recent Developments
  • 18.12 Melinta Therapeutics
    • 18.12.1. Melinta Therapeutics: Company Snapshot
    • 18.12.2. Melinta Therapeutics: Company Overview
    • 18.12.3. Melinta Therapeutics: Financials
    • 18.12.4. Melinta Therapeutics: Recent Developments
  • 18.13 SHIONOGI Co., Ltd.
    • 18.13.1. SHIONOGI Co., Ltd.: Company Snapshot
    • 18.13.2. SHIONOGI Co., Ltd.: Company Overview
    • 18.13.3. SHIONOGI Co., Ltd.: Financials
    • 18.13.4. SHIONOGI Co., Ltd.: Recent Developments
  • 18.14 DAIICHI SANKYO COMPANY, LIMITED.
    • 18.14.1. DAIICHI SANKYO COMPANY, LIMITED.: Company Snapshot
    • 18.14.2. DAIICHI SANKYO COMPANY, LIMITED.: Company Overview
    • 18.14.3. DAIICHI SANKYO COMPANY, LIMITED.: Financials
    • 18.14.4. DAIICHI SANKYO COMPANY, LIMITED.: Recent Developments
  • 18.15 Johnson & Johnson Services, Inc.
    • 18.15.1. Johnson & Johnson Services, Inc.: Company Snapshot
    • 18.15.2. Johnson & Johnson Services, Inc.: Company Overview
    • 18.15.3. Johnson & Johnson Services, Inc.: Financials
    • 18.15.4. Johnson & Johnson Services, Inc.: Recent Developments

19 Conclusion and Recommendations

  • 19.1 Market Dynamics and Funding Situation
  • 19.2 Current Clinical Pipeline Remains Insufficient Against Priority Pathogens
  • 19.3 Non-traditional approaches are attracting R&D interest
  • 19.4 Pipeline Outlook Remains Bleak
  • 19.5 Non-traditional approaches are attracting R&D interest

List of Tables

  • Table 1 Global Antibacterial Drugs Market Snapshot, 2020&2030 (US$ million, CAGR %)
  • Table 2 Global Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 3 Global Antibacterial Drugs Market for Cephalosporins Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 4 "V" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 5 "U" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 6 "W" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 7 "L" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 8 Global Antibacterial Drugs Market for Penicillin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 9 "V" Shaped Recovery: Global Antibacterial Drugs Market for Penicillin Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 10 "U" Shaped Recovery: Global Antibacterial Drugs Market for Penicillin Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 11 "W" Shaped Recovery: Global Antibacterial Drugs Market for Penicillin's Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 12 "L" Shaped Recovery: Global Antibacterial Drugs Market for Penicillin's Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 13 Global Antibacterial Drugs Market for Fluoroquinolones Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 14 "V" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 15 "U" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 16 "W" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 17 "L" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 18 Global Antibacterial Drugs Market for Macrolides Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 19 "V" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 20 "U" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 21 "W" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 22 "L" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 23 Global Antibacterial Drugs Market for Carbapenems Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 24 "V" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 25 "U" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 26 "W" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 27 "L" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 28 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 29 "V" Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 30 "U" Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 31 "W" Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 32 "L" Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 33 Global Antibacterial Drugs Market Forecast by Cephalosporins, By Products, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 34 Global Antibacterial Drugs Market for Rocephin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 35 Global Antibacterial Drugs Market for Sulperazon Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 36 Global Antibacterial Drugs Market for Ceftin/Zinnat Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 37 Global Antibacterial Drugs Market for Meiact Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 38 Global Antibacterial Drugs Market for Flomox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 39 Global Antibacterial Drugs Market for Teflaro Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 40 Global Antibacteral Drugs Market for Zeftera Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 41 Global Antibacterial Drugs Market for Ceftolozane-tazobactam Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 42 Global Antibacterial Drugs Market for Ceftazidime-Avibactam Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 43 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 44 Global Antibacterial Drugs Market Forecast by Penicillins, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 45 Global Antibacterial Drugs Market for Generic Amoxicillin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 46 Global Antibacterial Drugs Market for Augmentin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 47 Global Antibacterial Drugs Market for Zosyn/Tazocin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 48 Global Antibacterial Drugs Market for Unasyn Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 49 Global Antibacterial Drugs Market for Generic amoxicllin-clavulanic acid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 50 Global Antibacterial Drugs Market for Amoxil Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 51 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 52 Global Antibacterial Drugs Market Forecast by Fluoroquinolones, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 53 Global Antibacterial Drugs Market for Avelox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 54 Global Antibacterial Drugs Market for Cravit Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 55 Global Antibacterial Drugs Market for Vigamox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 56 Global Antibacterial Drugs Market for Ciprodex Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 57 Global Antibacterial Drugs Market for Cipro/Cirpobay Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 58 Global Antibacterial Drugs Market for Geninax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 59 Global Antibacterial Drugs Market for Baxdela Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 60 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 61 Global Antibacterial Drugs Market Forecast by Macrolides, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 62 Global Antibacterial Drugs Market for Biaxin/Clarith Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 63 Global Antibacterial Drugs Market for Zithromax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 64 Global Antibacterial Drugs Market for Dalacin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 65 Global Antibacterial Drugs Market for Dificid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 66 Global Antibacterial Drugs Market for Solithromycin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 67 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 68 Global Antibacterial Drugs Market Forecast by Carbapenems, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 69 Global Antibacterial Drugs Market for Invanz Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 70 Global Antibacterial Drugs Market for Merrem/Meropen Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 71 Global Antibacterial Drugs Market for Primaxin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 72 Global Antibacterial Drugs Market for Doribax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 73 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 74 Global Antibacterial Drugs Market Forecast by Other Sectors, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 75 Global Antibacterial Drugs Market for Zyvox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 76 Global Antibacterial Drugs Market for Cubicin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 77 Global Antibacterial Drugs Market for Tygacil Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 78 Global Antibacterial Drugs Market for TOBI/TIP Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 79 Global Antibacterial Drugs Market for Solodyn Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 80 Global Antibacterial Drugs Market for Vibativ Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 81 Global Antibacterial Drugs Market for Sirturo Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 82 Global Antibacterial Drugs Market for Tedizolid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 83 Global Antibacterial Drugs Market for Oritavancin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 84 Global Antibacterial Drugs Market for Dalbavancin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 85 Global Antibacterial Drugs Market for Nemonoxacin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 86 Global Antibacterial Drugs Market for Surotomycin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 87 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 88 Global Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR %)
  • Table 89 Global Antibacterial Drugs Market for Hospital Pharmacies Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 90 "V" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 91 "U" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 92 "W" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 93 "L" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 94 Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 95 "V" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 96 "U" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 97 "W" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 98 "L" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 99 Global Antibacterial Drugs Market for E-Commerce Segment: Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 100 "V" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 101 "U" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 102 "W" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 103 "L" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%, CAGR%)
  • Table 104 Global Antibacterial Drugs Market Forecast by Region, 2020-2030 (US$ million, AGR %)
  • Table 105 "V" Shaped Recovery: Global Antibacterial Drugs Market Forecast by Region, 2020-2030 (US$ million, AGR %)
  • Table 106 "U" Shaped Recovery: Global Antibacterial Drugs Market Forecast by Region, 2020-2030 (US$ million, AGR %)
  • Table 107 "W" Shaped Recovery: Global Antibacterial Drugs Market Forecast by Region, 2020-2030 (US$ million, AGR %)
  • Table 108 "L" Shaped Recovery: Global Antibacterial Drugs Market Forecast by Region, 2020-2030 (US$ million, AGR %)
  • Table 109 North America Antibacterial Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %)
  • Table 110 North America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 111 North America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 112 U.S .Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 113 "V" Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast, 2020-2030
  • Table 114 "U" Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast, 2020-2030
  • Table 115 "W" Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast, 2020-2030
  • Table 116 "L" Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast, 2020-2030
  • Table 117 Canada Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 118 "V" Shaped Recovery Scenario: U.S. Antibacterial Drugs Market Forecast, 2020-2030
  • Table 119 "U" Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast, 2020-2030
  • Table 120 "W" Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast, 2020-2030
  • Table 121 "L" Shaped Recovery Scenario: Canada Antibacterial Drugs Market Forecast, 2020-2030
  • Table 122 Europe Antibacterial Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %)
  • Table 123 Europe Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 124 Europe Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 125 Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 126 "V" Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 127 "U" Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 128 "W" Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 129 "L" Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 130 France Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 131 "V" Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 132 "U" Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 133 "W" Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 134 "L" Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 135 UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 136 "V" Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 137 "U" Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 138 "W" Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 139 "L" Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 140 Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 141 "V" Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 142 "U" Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 143 "W" Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 144 "L" Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 145 Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 146 "V" Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 147 "U" Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 148 "W" Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 149 "L" Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 150 Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 151 "V" Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 152 "U" Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 153 "W" Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 154 "L" Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 155 Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 156 "V" Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 157 "U" Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 158 "W" Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 159 "L" Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Table 160 Asia Pacific Antibacterial Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %)
  • Table 161 Asia Pacific Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 162 Asia Pacific Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 163 Japan Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 164 "V" Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast, 2020-2030
  • Table 165 "U" Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast, 2020-2030
  • Table 166 "W" Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast, 2020-2030
  • Table 167 "L" Shaped Recovery Scenario: Japan Antibacterial Drugs Market Forecast, 2020-2030
  • Table 168 China Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 169 "V" Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast, 2020-2030
  • Table 170 "U" Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast, 2020-2030
  • Table 171 "W" Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast, 2020-2030
  • Table 172 "L" Shaped Recovery Scenario: China Antibacterial Drugs Market Forecast, 2020-2030
  • Table 173 India Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 174 "V" Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast, 2020-2030
  • Table 175 "U" Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast, 2020-2030
  • Table 176 "W" Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast, 2020-2030
  • Table 177 "L" Shaped Recovery Scenario: India Antibacterial Drugs Market Forecast, 2020-2030
  • Table 178 Australia Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 179 "V" Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast, 2020-2030
  • Table 180 "U" Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast, 2020-2030
  • Table 181 "W" Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast, 2020-2030
  • Table 182 "L" Shaped Recovery Scenario: Australia Antibacterial Drugs Market Forecast, 2020-2030
  • Table 183 South Korea Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 184 "V" Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast, 2020-2030
  • Table 185 "U" Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast, 2020-2030
  • Table 186 "W" Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast, 2020-2030
  • Table 187 "L" Shaped Recovery Scenario: South Korea Antibacterial Drugs Market Forecast, 2020-2030
  • Table 188 Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 189 "V" Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030
  • Table 190 "U" Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030
  • Table 191 "W" Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030
  • Table 192 "L" Shaped Recovery Scenario: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030
  • Table 193 Latin America Antibacterial Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %)
  • Table 194 Latin America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 195 Latin America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 196 Mexico Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 197 "V" Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
  • Table 198 "U" Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
  • Table 199 Middle East and Africa Antibacterial Drugs Market Forecast by Country, 2020-2030 (US$ million, AGR %)
  • Table 200 Middle East and Africa Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 201 Middle East and Africa Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %, CAGR%)
  • Table 202 GCC Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 203 "V" Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
  • Table 204 "U" Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
  • Table 205 "W" Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
  • Table 206 "L" Shaped Recovery Scenario: GCC Antibacterial Drugs Market Forecast 2020-2030
  • Table 207 South Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 208 "V" Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
  • Table 209 "U" Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
  • Table 210 "W" Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
  • Table 211 "L" Shaped Recovery Scenario: South Africa Antibacterial Drugs Market Forecast 2020-2030
  • Table 212 Rest of Middle East and Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Table 213 "V" Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
  • Table 214 "U" Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
  • Table 215 "W" Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
  • Table 216 "L" Shaped Recovery Scenario: Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030
  • Table 217 Pfizer Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 218 Novartis AG: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 219 Merck KGaA: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 220 GlaxoSmithKline PLC: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 221 BioVersys AG: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 222 Allecra Therapeutics GmbH: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 223 Adenium Biotech ApS: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 224 Bayer AG: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 225 Eli Lilly and Company: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 226 AstraZeneca PLC: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 227 AbbVie Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 228 Melinta Therapeutics: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 229 SHIONOGI Co., Ltd.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 230 DAIICHI SANKYO COMPANY, LIMITED.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 231 Johnson & Johnson Services, Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)

List of Figures

  • Figure 1 Global Antibacterial Drugs Market Segmentation
  • Figure 2 U.S. approvals of anti-infectives by year
  • Figure 3 Porter's Analysis
  • Figure 4 PEST Analysis
  • Figure 5 Value Chain Analysis
  • Figure 6 Global Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR %)
  • Figure 7 Global Antibacterial Drugs Market Share Forecast by Type, 2020, 2025, 2030 (%)
  • Figure 8 Global Antibacterial Drugs Market for Cephalosporins Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 9 "V" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 10 "U" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 11 "W" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 12 "L" Shaped Recovery: Global Antibacterial Drugs Market for Cephalosporins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 13 Global Antibacterial Drugs Market for Penicillins Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 14 "V" Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 15 "U" Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 16 "W" Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 17 "L" Shaped Recovery: Global Antibacterial Drugs Market for Penicillins Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 18 Global Antibacterial Drugs Market for Fluoroquinolones Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 19 "V" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 20 "U" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 21 "W" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 22 "L" Shaped Recovery: Global Antibacterial Drugs Market for Fluoroquinolones Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 23 Global Antibacterial Drugs Market for Macrolides Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 24 "V" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 25 "U" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 26 "W" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 27 "L" Shaped Recovery: Global Antibacterial Drugs Market for Macrolides Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 28 Global Antibacterial Drugs Market for Carbapenems Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 29 "V" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 30 "U" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 31 "W" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 32 "L" Shaped Recovery: Global Antibacterial Drugs Market for Carbapenems Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 33 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 34 "V" Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 35 "U" Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 36 "W" Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 37 "L" Shaped Recovery: Global Antibacterial Drugs Market for Others Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 38 Global Antibacterial Drugs Market Forecast by Cephalosporins, 2020-2030 (US$ million, AGR %)
  • Figure 39 Global Antibacterial Drugs Market Share Forecast by Cephalosporins, 2020, 2025, 2030 (%)
  • Figure 40 Global Antibacterial Drugs Market for Rocephin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 41 Global Antibacterial Drugs Market for Sulperazon Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 42 Global Antibacterial Drugs Market for Ceftin/Zinnat Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 43 Global Antibacterial Drugs Market for Meiact Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 44 Global Antibacterial Drugs Market for Flomox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 45 Global Antibacterial Drugs Market for Teflaro Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 46 Global Antibacterial Drugs Market for Zeftera Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 47 Global Antibacterial Drugs Market for Ceftolozane-tazobactam Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 48 Global Antibacterial Drugs Market for Ceftazidime-Avibactam Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 49 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 50 Global Antibacterial Drugs Market Forecast by Penicillins, 2020-2030 (US$ million, AGR %)
  • Figure 51 Global Antibacterial Drugs Market Share Forecast by Penicillins, 2020, 2025, 2030 (%)
  • Figure 52 Global Antibacterial Drugs Market for Generic Amoxicillin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 53 Global Antibacterial Drugs Market for Augmentin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 54 Global Antibacterial Drugs Market for Zosyn/Tazocin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 55 Global Antibacterial Drugs Market for Unasyn Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 56 Global Antibacterial Drugs Market for Generic amoxicllin-clavulanic acid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 57 Global Antibacterial Drugs Market for Amoxil Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 58 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 59 Global Antibacterial Drugs Market Forecast by Fluoroquinolones, 2020-2030 (US$ million, AGR %)
  • Figure 60 Global Antibacterial Drugs Market Share Forecast by Fluoroquinolones, 2020, 2025, 2030 (%)
  • Figure 61 Global Antibacterial Drugs Market for Avelox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 62 Global Antibacterial Drugs Market for Cravit Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 63 Global Antibacterial Drugs Market for Vigamox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 64 Global Antibacterial Drugs Market for Ciprodex Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 65 Global Antibacterial Drugs Market for Cipro/Cirpobay Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 66 Global Antibacterial Drugs Market for Geninax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 67 Global Antibacterial Drugs Market for Baxdela Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 68 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 69 Global Antibacterial Drugs Market Forecast by Macrolides, 2020-2030 (US$ million, AGR %)
  • Figure 70 Global Antibacterial Drugs Market Share Forecast by Macrolides, 2020, 2025, 2030 (%)
  • Figure 71 Global Antibacterial Drugs Market for Biaxin/Clarith Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 72 Global Antibacterial Drugs Market for Zithromax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 73 Global Antibacterial Drugs Market for Dalacin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 74 Global Antibacterial Drugs Market for Dificid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 75 Global Antibacterial Drugs Market for Solithromycin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 76 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 77 Global Antibacterial Drugs Market Forecast by Carbapenems, 2020-2030 (US$ million, AGR %)
  • Figure 78 Global Antibacterial Drugs Market Share Forecast by Carbapenems, 2020, 2025, 2030 (%)
  • Figure 79 Global Antibacterial Drugs Market for Invanz Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 80 Global Antibacterial Drugs Market for Merrem/Meropen Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 81 Global Antibacterial Drugs Market for Primaxin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 82 Global Antibacterial Drugs Market for Doribax Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 83 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 84 Global Antibacterial Drugs Market Forecast by Other Sectors, 2020-2030 (US$ million, AGR %)
  • Figure 85 Global Antibacterial Drugs Market for Zyvox Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 86 Global Antibacterial Drugs Market for Cubicin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 87 Global Antibacterial Drugs Market for Tygacil Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 88 Global Antibacterial Drugs Market for TOBI/TIP Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 89 Global Antibacterial Drugs Market for Solodyn Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 90 Global Antibacterial Drugs Market for Vibativ Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 91 Global Antibacterial Drugs Market for Sirturo Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 92 Global Antibacterial Drugs Market for Tedizolid Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 93 Global Antibacterial Drugs Market for Oritavancin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 94 Global Antibacterial Drugs Market for Dalbavancin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 95 Global Antibacterial Drugs Market for Nemonoxacin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 96 Global Antibacterial Drugs Market for Surotomycin Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 97 Global Antibacterial Drugs Market for Others Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 98 Global Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR %)
  • Figure 99 Global Antibacterial Drugs Market Share Forecast by Distribution Channel, 2020, 2025, 2030 (%)
  • Figure 100 Global Antibacterial Drugs Market for Hospital Pharmacies Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 101 "V" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 102 "U" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 103 "W" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 104 "L" Shaped Recovery: Global Antibacterial Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 105 Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 106 "V" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 107 "U" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 108 "W" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 109 "L" Shaped Recovery: Global Antibacterial Drugs Market for Drug Stores & Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 110 Global Antibacterial Drugs Market for E-Commerce Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 111 "V" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 112 "U" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 113 "W" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 114 "L" Shaped Recovery: Global Antibacterial Drugs Market for E-Commerce Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
  • Figure 115 Global Antibacterial Drugs Market Forecast by Region 2020-2030 (US$ million)
  • Figure 116 Global Antibacterial Drugs Market Share Forecast by Region 2020, 2025, 2030 (%)
  • Figure 117 North America Antibacterial Drugs Market Forecast by Country 2020-2030 (US$ million)
  • Figure 118 North America Antibacterial Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 119 North America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
  • Figure 120 North America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
  • Figure 121 U.S. Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 122 "V" Shaped Recovery: U.S. Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 123 "U" Shaped Recovery: U.S. Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 124 "W" Shaped Recovery: U.S. Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 125 "L" Shaped Recovery: U.S. Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 126 Canada Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 127 "V" Shaped Recovery: Canada Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 128 "U" Shaped Recovery: Canada Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 129 "W" Shaped Recovery: Canada Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 130 "L" Shaped Recovery: Canada Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 131 Europe Antibacterial Drugs Market Forecast by Country 2020-2030 (US$ million)
  • Figure 132 Europe Antibacterial Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 133 Europe Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
  • Figure 134 Europe Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
  • Figure 135 Germany Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 136 "V" Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 137 "U" Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 138 "W" Shaped Recovery: Germany Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 139 "L" Shaped Recovery: German y Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 140 France Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 141 "V" Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 142 "U" Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 143 "W" Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 144 "L" Shaped Recovery: France Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 145 UK Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 146 "V" Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 147 "U" Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 148 "W" Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 149 "L" Shaped Recovery: UK Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 150 Italy Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 151 "V" Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 152 "U" Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 153 "W" Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 154 "L" Shaped Recovery: Italy Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 155 Spain Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 156 "V" Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 157 "U" Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 158 "W" Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 159 "L" Shaped Recovery: Spain Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 160 Russia Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 161 "V" Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 162 "U" Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 163 "W" Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 164 "L" Shaped Recovery: Russia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 165 Rest of Europe Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 166 "V" Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 167 "U" Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 168 "W" Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 169 "L" Shaped Recovery: Rest of Europe Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 170 Asia Pacific Antibacterial Drugs Market Forecast by Country 2020-2030 (US$ million)
  • Figure 171 Asia Pacific Antibacterial Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 172 Asia Pacific Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
  • Figure 173 Asia Pacific Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
  • Figure 174 Japan Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 175 "V" Shaped Recovery: Japan Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 176 "U" Shaped Recovery: Japan Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 177 "W" Shaped Recovery: Japan Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 178 "L" Shaped Recovery: Japan Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 179 China Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 180 "V" Shaped Recovery: China Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 181 "U" Shaped Recovery: China Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 182 "W" Shaped Recovery: China Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 183 "L" Shaped Recovery: China Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 184 India Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 185 "V" Shaped Recovery: India Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 186 "U" Shaped Recovery: India Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 187 "W" Shaped Recovery: India Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 188 "L" Shaped Recovery: India Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 189 Australia Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 190 "V" Shaped Recovery: Australia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 191 "U" Shaped Recovery: Australia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 192 "W" Shaped Recovery: Australia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 193 "L" Shaped Recovery: Australia Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 194 South Korea Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 195 "V" Shaped Recovery: South Korea Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 196 "U" Shaped Recovery: South Korea Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 197 "W" Shaped Recovery: South Korea Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 198 "L" Shaped Recovery: South Korea Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 199 Rest of Asia Pacific Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 200 "V" Shaped Recovery: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 201 "U" Shaped Recovery: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 202 "W" Shaped Recovery: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 203 "L" Shaped Recovery: Rest of Asia Pacific Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 204 Latin America Antibacterial Drugs Market Forecast by Country 2020-2030 (US$ million)
  • Figure 205 Latin America Antibacterial Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 206 Latin America Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
  • Figure 207 Latin America Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
  • Figure 208 Brazil Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Figure 209 Brazil Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 210 "V" Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
  • Figure 211 "V" Shaped Recovery: Brazil Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 212 "U" Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
  • Figure 213 "U" Shaped Recovery: Brazil Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 214 "W" Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
  • Figure 215 "W" Shaped Recovery: Brazil Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 216 "L" Shaped Recovery Scenario: Brazil Antibacterial Drugs Market Forecast 2020-2030
  • Figure 217 "L" Shaped Recovery: Brazil Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 218 Mexico Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 219 "V" Shaped Recovery: Mexico Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 220 "U" Shaped Recovery: Mexico Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 221 "W" Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
  • Figure 222
  • Figure 223 "W" Shaped Recovery: Mexico Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 224 "L" Shaped Recovery Scenario: Mexico Antibacterial Drugs Market Forecast 2020-2030
  • Figure 225 "L" Shaped Recovery: Mexico Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 226 Argentina Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Figure 227 Argentina Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 228
  • Figure 229 "V" Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
  • Figure 230 "V" Shaped Recovery: Argentina Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 231
  • Figure 232 "U" Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
  • Figure 233 "U" Shaped Recovery: Argentina Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 234 "W" Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
  • Figure 235 "W" Shaped Recovery: Argentina Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 236 "L" Shaped Recovery Scenario: Argentina Antibacterial Drugs Market Forecast 2020-2030
  • Figure 237 "L" Shaped Recovery: Argentina Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 238 Rest of Latin America Antibacterial Drugs Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
  • Figure 239 Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 240 "V" Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
  • Figure 241
  • Figure 242 "V" Shaped Recovery: Rest of Latin America Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 243
  • Figure 244 "U" Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
  • Figure 245 "U" Shaped Recovery: Rest of Latin America Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 246 "W" Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
  • Figure 247 "W" Shaped Recovery: Rest of Latin America Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 248 "L" Shaped Recovery Scenario: Rest of Latin America Antibacterial Drugs Market Forecast 2020-2030
  • Figure 249 "L" Shaped Recovery: Rest of Latin America Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 250 Middle East and Africa Antibacterial Drugs Market Forecast by Country 2020-2030 (US$ million)
  • Figure 251 Middle East and Africa Antibacterial Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 252 Middle East and Africa Antibacterial Drugs Market Forecast by Type, 2020-2030 (US$ million, AGR%)
  • Figure 253 Middle East and Africa Antibacterial Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ million, AGR%)
  • Figure 254 GCC Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 255 "V" Shaped Recovery: GCC Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 256 "U" Shaped Recovery: GCC Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 257 "W" Shaped Recovery: GCC Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 258 "L" Shaped Recovery: GCC Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 259 South Africa Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 260 "V" Shaped Recovery: South Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 261 "U" Shaped Recovery: South Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 262 "W" Shaped Recovery: South Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 263 "L" Shaped Recovery: South Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 264 Rest of Middle East and Africa Antibacterial Drugs Market Forecast 2020-2030 (US$ million, AGR %)
  • Figure 265 "V" Shaped Recovery: Rest of Middle East and Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 266 "U" Shaped Recovery: Rest of Middle East and Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 267 "W" Shaped Recovery: Rest of Middle East and Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 268 "L" Shaped Recovery: Rest of Middle East and Africa Antibacterial Drugs Market Forecast, 2020-2030 (US$ million, AGR%)
  • Figure 269 Pfizer Inc. : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 270 Novartis AG : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 271 Merck KGaA : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 272 GlaxoSmithKline PLC : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 273 BioVersys AG : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 274 Allecra Therapeutics GmbH : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 275 Adenium Biotech ApS : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 276 Bayer AG : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 277 Eli Lilly and Company : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 278 AstraZeneca PLC : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 279 Abbvie : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 280 Melinta Therapeutics : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 281 SHIONOGI Co., Ltd. : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 282 DAIICHI SANKYO COMPANY, LIMITED. : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 283 Johnson & Johnson Services, Inc. : Company Financials, 2015-2019 (US$ Mn, AGR%)
  • Figure 284 Antibacterial agents in clinical development (Phase 1-3) as of September 2019
  • Figure 285 Summary of antibiotics in the clinical pipeline targeting the WHO priority pathogens

Companies Listed:

  • AbbVie Inc.
  • Achaogen
  • Adenium Biotech ApS
  • Alaxia Pharma
  • Allecra Therapeutics
  • Allergan, Actelion
  • AstraZeneca PLC
  • Bayer AG
  • Biocidium Biopharmaceuticals
  • BioVersys AG
  • Bugworks
  • Cadila Healthcare
  • Cellceutix Corporation
  • Cempra
  • ContraFect
  • DAIICHI SANKYO COMPANY, LIMITED
  • DebioPharm
  • Dr. Reddy's Laboratories
  • Eli Lilly and Company
  • Evotec Pharmaceuticals
  • EYDO Pharma
  • Galapagos
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Kyorin Pharmaceutical
  • Lupin
  • Macleod Pharmaceuticals
  • Meiji Seika Pharma
  • Melinta Therapeutics
  • Merck KGaA
  • MerLion Pharmaceuticals
  • MGB-Biopharma
  • MicuRx Pharmaceuticals
  • Nabriva Therapeutics
  • Nektar Therapeutics
  • Northern Antibiotics
  • Novartis AG
  • Ostuka
  • Paratek Pharmaceuticals
  • Pfizer Inc.
  • Phico Therapeutics
  • Redx Pharma
  • Savara Pharmaceuticals
  • SHIONOGI Co., Ltd.
  • Summit Therapeutics
  • The Medicines Company
  • Theravance Biopharma
  • Torrent Pharmaceuticals
  • TTY Biopharma
  • Unichem Laboratories
  • Wockhardt
  • Zydus Pharmaceuticals, Inc.

Organizations Mentioned in the Report:

  • Centers for Disease Control and Prevention
  • European Medicines Agency (EMA)
  • Food and Drug Administration (FDA)
  • International Society of Antimicrobial Chemotherapy
  • National Institute for Health and Clinical Excellence (NICE)
  • National Institutes of Health (NIH)
  • World Health Organization (WHO)